Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
申请人:BEECHAM GROUP PLC
公开号:EP0220011A2
公开(公告)日:1987-04-29
A method of treatment of undesirable actions of 5-HT on the gastro-intestinal tract; migraine, cluster headaches and trigeminal neuralgia, cytotoxic agent or radiation induced nausea and vomiting and/or arrhythmia in mammals, including humans, which method comprises administering an efffe- ctive amount of a compound of formula (I) or a pharmaceutic- allv acceptable salt thereof:
wherein:
R is amino or C1-7 acylamino;
X is chloro, bromo or C1-6 alkylthio; and
p is 0 or 1; novel compounds within formula (I)
wherein X is bromo or C,.6 alkylthio, a process for their preparation and their use as pharmaceuticals.
一种治疗 5-HT 对胃肠道的不良作用、偏头痛、丛集性头痛和三叉神经痛、细胞毒素或辐射诱发的恶心和呕吐和/或哺乳动物(包括人类)心律失常的方法,该方法包括施用有效量的式(I)化合物或其药学上可接受的盐:
其中
R 是氨基或 C1-7 氨基酰基;
X 是氯、溴或 C1-6 烷硫基;以及
p 为 0 或 1;式(I)中的新型化合物
其中 X 为溴代或 C,.6-烷硫基,其制备方法及其作为药物的用途。